The UK’s Department for Health is launching NHSX, a new unit with responsibility for setting national policy and developing best practice for NHS technology.
Inovia Capital, the Canadian VC firm, has raised two new funds totalling US$600 million: an early-stage fund of $200 million; and a growth-stage of $400 million. The funds will be invested in its existing markets in Canada and Silicon Valley, as well as through a new office in London.
Vicarious Surgical, a company working on minimally-invasive surgery, has raised a further $10 million from Gates Frontier, Khosla Ventures, Innovation Endeavours, AME Cloud Ventures, and Marc Benioff.
At HIMSS19, one theme seems to filter through all the buzz and activity: delivering value-based, patient-centred care.
NHS England wants to catch lung cancer before it’s too late with the roll-out of mobile scanning units. £70 million is going to fund ten projects to check people at highest risk.
The OneTouch Select Plus blood glucose monitoring system is the subject of a long-term study published this week in the Journal of Diabetes Science and Technology (JDST), and demonstrates the accuracy of its readings.
DNAnexus, the bioinformatics company, has closed a $68 million financing round from a combination of existing investors, including GV, Foresite Capital, TPG Biotech, WuXi NextCODE and Claremont Creek Ventures, and debt and equity from Innovatus Capital Partners.
Genomics England has selected QIAGEN to provide bioinformatic support to the NHS Genomic Medicine Service and its national network of Genomic Laboratory Hubs for 5 million genome project.
For radiation oncologists, the laborious task of determining the treatment plan for cancer patients is being simplified and shortened with the application of AI software from Finnish company MVision.
Constrained by workforce shortages during the difficult winter period, Dartford and Gravesham NHS Trust deployed Current, an AI-enabled wearable platform, to remotely monitor patients after being discharged from hospital.